0
0
Healthcare in India is set to become more affordable as new GST (Goods and Services Tax) rates, effective from September 22, 2025, reduce the tax burden on medicines, medical devices, and health-related services. This reform aims to improve access to essential healthcare for all citizens by lowering costs and easing the financial strain on patients and families.
Key Changes in GST for Healthcare
The new GST structure has significantly reduced the tax rates on most medicines, dropping them from 12% to 5%. Notably, 36 critical life-saving drugs, including those for cancer, genetic and rare diseases, and cardiovascular conditions, have been fully exempted from GST. This sweeping exemption alleviates costs for patients facing serious health challenges. Additionally, the GST Council has rationalized tax slabs on health insurance premiums, life insurance premiums, glucometers, and corrective eyewear, standardizing rates to support affordability across the healthcare spectrum.
Expert Perspectives
Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), highlighted this development as a “transformative shift” in India’s healthcare landscape, ensuring direct savings for patients and strengthening healthcare security. IPA, representing 23 major research-driven pharmaceutical companies, pledges to facilitate the swift and transparent transfer of these benefits to consumers.
Anil Matai, Director General of the Organisation of Pharmaceutical Producers of India (OPPI), described the decision as “historic and compassionate,” emphasizing the critical relief it offers by reducing the GST completely to nil on 33 essential drugs and cutting it to zero on three critical medicines previously taxed at 5%. He stressed how these changes would facilitate better affordability and accessibility in healthcare from hospitals down to households.
Ameera Shah, President of NATHEALTH and Executive Chairperson of Metropolis Healthcare Ltd, added that easing the cost burden supports early disease detection and improves access to quality healthcare. She also noted the benefit of GST rate standardization across preventive, curative, and rehabilitative services, which could improve consistency in healthcare delivery.
Context and Background
India’s GST system previously imposed multiple tax slabs on medicines and medical devices, creating complexity and uneven pricing in healthcare. Essential drugs often faced a 12% tax, compounding the financial burden on patients with chronic or life-threatening illnesses. The government’s announcement to lower these rates is part of a broader reform strategy to make healthcare services more accessible and affordable in a country where out-of-pocket expenditure on health remains high.
India’s healthcare affordability issues have long been a barrier to equitable health outcomes, with significant segments of the population struggling to afford essential medicines and diagnostics. According to the National Sample Survey Office (NSSO), out-of-pocket health expenses constitute about 60-70% of total health spending in India, often pushing families into poverty.
Public Health Implications
Lower GST rates on essential medicines and devices hold the promise of improved medication adherence, especially among economically vulnerable populations. By reducing out-of-pocket expenses, patients may be more likely to initiate and continue treatments for chronic and life-threatening conditions, such as cancer and cardiovascular diseases, potentially improving health outcomes and reducing disease complications.
The reduction in tax on glucometers and corrective spectacles enhances accessibility to preventive and diagnostic tools for diabetes and vision health — conditions prevalent in India and responsible for substantial morbidity if left unmanaged.
These GST reforms support the government’s ongoing push toward Universal Health Coverage (UHC) and align with national health missions aimed at reducing financial barriers to healthcare.
Potential Limitations and Considerations
While tax reductions are a critical step, experts caution that affordability is influenced by multiple factors, including supply chain efficiency, pricing regulations, and healthcare infrastructure. Lower GST alone may not fully translate into reduced prices if manufacturers or retailers do not pass on the savings to consumers transparently.
Moreover, these changes do not address indirect costs such as consultation fees, diagnostic tests, or hospital charges that also contribute significantly to healthcare expenses.
Continued vigilance and policy measures are necessary to ensure that the tax benefits reach all strata of society equally and facilitate broader systemic improvements.
Practical Implications for Readers
For consumers and patients, this GST reform means that many medicines and health products, especially those critical for managing severe and chronic illnesses, will become more affordable starting late September 2025. People managing conditions like cancer, rare genetic disorders, cardiovascular diseases, or diabetes may notice savings when purchasing medicines or devices like glucometers.
Healthcare providers and pharmacists will play a key role in informing patients about these changes, and consumers should ask about the implications for pricing in their local pharmacies or healthcare facilities.
Conclusion
The Indian government’s GST reform marks a significant milestone in efforts to make healthcare more affordable and accessible nationwide. By lowering taxes on medicines, medical devices, and health insurance products, it aims to reduce the financial burden on millions of patients, promote early diagnosis and treatment, and pave the way for stronger healthcare security for all citizens.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Economic Times Health, “Healthcare set to be more affordable as new GST rate kicks in,” September 22, 2025.
- https://health.economictimes.indiatimes.com/news/policy/new-gst-rates-to-make-healthcare-more-affordable-in-india/124035320?utm_source=top_story&utm_medium=homepage
